Skip to main content
. 2018 Dec 21;65(4):309–317. doi: 10.5606/tftrd.2019.3126

Table 1. Demographic and disease related characteristics of the patients with breast cancer-related lymphedema.

  CB Group (n=14) CB/SLD Group (n=10) p
  n % Mean±SD Median Min-Max n % Mean±SD Median Min-Max  
Age (year)   61.64±11.69 5 0-13   55.20±7.15 8 0-11 0.131 0.382 0.080 1.000
BMI (kg/m2)   32.73±5.80       30.88±3.62      
Education (year) Marital status                  
Married 9 64,3     7 70      
Single 5 36,7     3 30      
Arm dominance                 0,163
Right 14 100     8 80      
Left 0 0     2 20      
Comorbidity                 0,665
Yes 11 78,6     7 70      
No 3 21,4     3 30      
Pathological diagnosis                 1,000
İnfiltrative ductal carcinoma 12 85,7     9 90      
İnfiltrative lobular carcinoma 2 14,3     1 10      
Cancer stage                 *
Stage 1 3 21,4     2 20      
Stage 2 4 28,6     4 40      
Stage 3 7 50     4 40      
Type of surgery                 1,000
BCS+ALND 1 7,1     1 10      
MRM+ALND 13 92,9     9 90      
Lymph nodes removed from axilla     23 11-52     17,5 10-22 0,071
Metastatic lymph nodes     1,50 0-33     2,50 0-6 0,663
Chemotherapy                 0,615
Yes 11 78,6     9 90      
No 3 21,4     1 10      
Radiotherapy                 0,388
Yes 8 57,1     8 80      
No 6 42,9     2 20      
Hormone therapy                 0,678
Yes 8 57,1     7 70      
No 6 42,9     3 30      
Affected arm                 0,240
Dominant 6 42,9     7 70      
Non-dominant 8 78,6     3 30      
Location of swelling                 *
FA 1 7,1     1 10      
UA 6 42,9     2 20      
Whole arm 1 7,1     1 10      
Wrist+FA+UA 5 35,7     3 30      
FA+UA 1 7,1     3 30      
LE stage                 1,000
Stage 1 3 21,4     2 20      
Stage 2 11 78,6     8 80      
LE severity                 *
Mild 3 21,4     2 20      
Moderate 10 71,4     6 60      
Severe 1 7,1     2 20      
Time from surgery (month)     21 3-83     21,5 3-252 0,780
Duration of LE (month)     2 1-12     1 1-36 0,791
Duration of treatment phase (week)     5 4-8     6 4-20 0,255
CB: Compression bandaging; SLD: Self-lymphatic drainage; SD: Standard deviation; Min: Minimum; Max: Maximum; BMI: Body mass index; BCS: Breast conserving surgery; ALND: Axiller lymph node dissection; MRM: Modified radical mastectomy; FA: Forearm; UA: Upper arm; LE: Lymphedema; * p-values for location of swelling , cancer stage and LE severity couldn’t be calculated since the counts are too small.